Rabeprazole

Rabeprazole is a pharmaceutical-grade active ingredient classified as a Proton Pump Inhibitor (PPI) Benzimidazole derivative. Mediocon Inc supplies high-purity Rabeprazole API conforming to IP / BP / EP / USP specifications, manufactured in our GMP-certified facility in Aurangabad, Maharashtra, India.

Rabeprazole is a potent proton pump inhibitor that irreversibly blocks the H+/K+-ATPase enzyme system in gastric parietal cells, effectively suppressing acid secretion. It is used for the treatment of gastroesophageal reflux disease (GERD), peptic ulcers, Zollinger-Ellison syndrome, and Helicobacter pylori eradication.

Key Features

• High-purity pharmaceutical grade API
• IP/BP/EP/USP compliant
• Full CoA and MSDS documentation
• GMP certified manufacturing

Applications

• Gastroesophageal reflux disease (GERD)
• Duodenal and gastric ulcer healing
• H. pylori eradication (triple therapy)
• Zollinger-Ellison syndrome management

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings